{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:49:35Z","timestamp":1764841775450},"reference-count":10,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2014.00185","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T10:12:10Z","timestamp":1407406330000},"source":"Crossref","is-referenced-by-count":1,"title":["Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy"],"prefix":"10.3389","volume":"5","author":[{"given":"Ryan M.","family":"Fryer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine M.","family":"Boustany-Kari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"MacDonnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.semnephrol.2012.02.006","article-title":"The endothelium in diabetic nephropathy","volume":"32","author":"Advani","year":"2012","journal-title":"Semin. Nephrol"},{"issue":"71","key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00071","article-title":"Erk5 is a mediator to TGFbeta1-induced loss of phenotype and function in human podocytes","volume":"5","author":"Badshah","year":"2014","journal-title":"Front. Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"23","key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00023","article-title":"Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease","volume":"5","author":"Chugh","year":"2014","journal-title":"Front. Pharmacol"},{"issue":"70","key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00070","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes","volume":"5","author":"Kanasaki","year":"2014","journal-title":"Front. Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"115","key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00115","article-title":"PF-03882845 a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy","volume":"4","author":"Orena","year":"2013","journal-title":"Front. Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2337\/diabetes.51.10.3083","article-title":"Podocyte number in normotensive type 1 diabetic patients with albuminuria","volume":"51","author":"White","year":"2002","journal-title":"Diabetes"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T19:50:34Z","timestamp":1424289034000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2014.00185\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.3389\/fphar.2014.00185","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,7]]}}}